Physician
Leblanc Pediatrics LLC
Leblanc Pediatrics LLC was paid $4.84M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 42% of everything it billed.
33Billing provider infoLEBLANC PEDIATRICS LLC
MANDEVILLE, LA 70471
MANDEVILLE, LA 70471
33aNPI1386928042assigned 09/29/2011
33bProvider typePediatrics Physician
28Total paid$4.84M
24GClaims265,069
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#31 of 230
Median peer was paid$429K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,547 | $547K | |
| 2019 | 25,165 | $576K | |
| 2020 | 25,783 | $519K | |
| 2021 | 30,618 | $733K | |
| 2022 | 53,206 | $838K | |
| 2023 | 58,178 | $822K | |
| 2024incomplete | 49,572 | $804K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 42% | 51,774 | 43,467 | $2.04M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 13,072 | 11,356 | $762K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.6% | 8,297 | 7,169 | $465K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.1% | 7,485 | 6,528 | $438K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.9% | 16,154 | 13,521 | $189K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.4% | 2,704 | 2,489 | $165K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.9% | 9,638 | 8,432 | $143K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.6% | 15,491 | 11,134 | $125K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.5% | 4,816 | 3,433 | $121K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 17,453 | 13,817 | $62K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 857 | 758 | $53K |
| 99381 | 1.1% | 820 | 730 | $53K |
48 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,218 | $48K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 925 | $26K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 330 | $23K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 299 | $22K |
| 83655 | <1% | 2,755 | $18K | |
| 99051 | <1% | 1,056 | $15K | |
| 90474 | <1% | 1,505 | $11K | |
| 87807 | <1% | 1,648 | $11K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 108 | $11K |
| 87634 | <1% | 116 | $6K | |
| 92551 | <1% | 710 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 78 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 549 | $5K |
| 85018 | <1% | 3,310 | $4K | |
| 99173 | <1% | 2,472 | $4K | |
| 81002 | <1% | 1,604 | $3K | |
| 80061 | Lipid panel | <1% | 350 | $3K |
| 99383 | <1% | 29 | $2K | |
| 99382 | <1% | 27 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 40 | $1K |
| 90647 | <1% | 1,344 | $702.52 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 423 | $533.56 |
| 90677 | <1% | 39 | $371.95 | |
| 82947 | <1% | 123 | $359.72 | |
| 90716 | <1% | 1,905 | $260.00 | |
| 90670 | <1% | 3,873 | $214.62 | |
| 90651 | <1% | 256 | $205.16 | |
| 86308 | <1% | 51 | $191.19 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 21 | $81.25 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 43 | $77.50 |
| 90707 | <1% | 1,931 | $76.43 | |
| 90661 | <1% | 93 | $73.70 | |
| 90686 | <1% | 2,179 | $58.59 | |
| 94760 | <1% | 18 | $2.19 | |
| 90633 | <1% | 1,982 | $1.49 | |
| 90723 | 0% | 3,019 | $0.00 | |
| 90680 | 0% | 902 | $0.00 | |
| 90696 | 0% | 277 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 157 | $0.00 |
| 87081 | 0% | 732 | $0.00 | |
| 90674 | 0% | 124 | $0.00 | |
| 1159F | 0% | 45,758 | $0.00 | |
| 1160F | 0% | 24,629 | $0.00 | |
| 90681 | 0% | 1,237 | $0.00 | |
| 90700 | 0% | 771 | $0.00 | |
| 90734 | 0% | 389 | $0.00 | |
| 90685 | 0% | 17 | $0.00 | |
| 90715 | 0% | 86 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEBLANC, JOSHUA (CEO)